Frontlight ResearchEarly access
Trial site
Accout Center s.r.o.
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis9 trials
- Crohn's disease3 trials
- Coeliac disease1 trial
- Phase
- Phase 27 trials
- Phase 35 trials
- Status
- Completed4 trials
- Recruiting4 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Abivax S.A.3 trials
- Takeda3 trials
- Eli Lilly & Co.1 trial
- Eli Lilly and Company1 trial
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Recruiting
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease3 recruiting
- Ulcerative colitis2 recruiting
Closed trials
Active, not recruiting
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
VTX002 versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026